Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Affimed (AFMD)
NASDAQ:AFMD
Affimed (AFMD) Stock Price & Analysis
622 Followers
AFMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.55 - $3.40
Previous Close$0.75
Volume698.06K
Average Volume (3M)772.44K
Market Cap
$112.75M
Enterprise Value-$59.35M
Total Cash (Recent Filing)€190.29M
Total Debt (Recent Filing)€18.19M
Price to Earnings (P/E)-1.1
Beta1.36
Next Earnings
Aug 09, 2023EPS Estimate
-$0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.71
Shares Outstanding149,340,000
10 Day Avg. Volume1,055,486
30 Day Avg. Volume772,441
Standard Deviation0.34
R-Squared0.16
Alpha0.00117
Financial Highlights & Ratios
Price to Book (P/B)0.86
Price to Sales (P/S)2.73
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$4.25Price Target Upside465.99% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Affimed News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AFMD FAQ
What was Affimed’s price range in the past 12 months?
Affimed lowest stock price was $0.55 and its highest was $3.40 in the past 12 months.
What is Affimed’s market cap?
Currently, no data Available
When is Affimed’s upcoming earnings report date?
Affimed’s upcoming earnings report date is Aug 09, 2023 which is in 62 days.
How were Affimed’s earnings last quarter?
Affimed released its earnings results on May 23, 2023. The company reported -$0.225 earnings per share for the quarter, missing the consensus estimate of -$0.205 by -$0.019.
Is Affimed overvalued?
According to Wall Street analysts Affimed’s price is currently Undervalued.
Does Affimed pay dividends?
Affimed does not currently pay dividends.
What is Affimed’s EPS estimate?
Affimed’s EPS estimate is -$0.2.
How many shares outstanding does Affimed have?
Affimed has 149,339,340 shares outstanding.
What happened to Affimed’s price movement after its last earnings report?
Affimed reported an EPS of -$0.225 in its last earnings report, missing expectations of -$0.205. Following the earnings report the stock price went down -9.346%.
Which hedge fund is a major shareholder of Affimed?
Among the largest hedge funds holding Affimed’s share is Baker Bros Advisors LP. It holds Affimed’s shares valued at 5M.
---
Affimed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.25 (465.99% Upside)
$4.25 (465.99% Upside)
Blogger Sentiment
Neutral
AFMD Sentiment 50%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 668.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 2.1%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-73.26%
12-Months-Change
Fundamentals
Return on Equity
-79.30%
Trailing 12-Months
Asset Growth
-15.13%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Affimed
Affimed NV engages in discovering and developing of targeted cancer immunotherapies. Its pipelines include Innate Cell Engagers and T Cell Engagers. The company was founded in 2000 and is headquartered in Heidelberg, Germany.
---
Top 5 ETFs holding AFMD
iShares NASDAQ US Biotechnology UCITS ETF
$61.83K
Invesco Nasdaq Biotechnology ETF
$2.50K
Up to five ETFs with an Outperform Smart Score that hold AFMD. The ETFs are listed according to market value of AFMD within the ETF
---
---